High-risk neuroblastoma in Ontario: A report of experience from 1989 to 1995

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 1, 2003, Pages 8-13

  Klaassen, Robert J ^a   Trebo, Monika M ^b   Koplewitz, Benjamin Z ^c   Weitzman, Sheila S ^d   Calderwood, Stanley ^e  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Autologous; Bone marrow transplant; Child; Cohort studies; Neuroblastoma; Ontario ep; Transplant

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW METASTASIS; CANADA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG RESPONSE; GENE AMPLIFICATION; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; POPULATION RESEARCH; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ADOLESCENT; BONE MARROW TRANSPLANTATION; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE AMPLIFICATION; GENES, MYC; HUMANS; INFANT; MALE; NEOPLASM STAGING; NEUROBLASTOMA; ONTARIO; POPULATION SURVEILLANCE; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING;

EID: 0037224969     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200301000-00004     Document Type: Article

References (13)

1. Bernstein M, Leclerc J, Bunin G, et al. A population-based study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol 1992; 10:323-9.
2. Carlsen NL. Neuroblastomas in Denmark 1943-80. Epidemiological and clinical studies. Acta Pediatrica. Supplement 1994;403:1-27.
3. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-73.
4. Philip T, Ladenstein R, Lasset C, et al. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumor Working Party. Eur J Cancer 1997;33:2130-5.
5. Grupp SA, Stem JW, Bunin N, et al. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol 2000;18: 2567-75.
6. Kanold J, Yakouben K, Tchirkov A, et al. Long-term results of CD34 (+) cell transplantation in children with neuroblastoma. Med Pediatr Oncol 2000;35: 1-7.
7. Ross JA, Severson RK, Pollock BH, et al. Childhood cancer in the United States: a geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer 1996;77:201-7.
8. Cotterill SJ, Pearson AD, Pritchard J, et al. Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey." Med Pediatr Oncol 2001;36:235-8.
9. Buckner CD, Clift RA, Sanders JE. et al. Marrow harvesting from normal donors. Blood 1984;64:630-4.
10. Pole JG, Gee A, Janssen W, et al. Immunomagnetic purging of bone marrow: a model for negative cell selection. Am J Pediatr Hematol Oncol 1990;12:257-61.
11. + selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma. Bone Marrow Transplant 2000; 25:1175-84.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Society 1958;53:457-87.
13. Kletzel M, Abella EM, Sandler ES, et al. Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and Marrow Transplant Consortium. J Pediatr Hematol Oncol 1998;20:49-54.